MEDIPHARM LABS CORP - PHASE II LIBBY TRIAL TREATMENT BENEFITS SUSTAINED THROUGHOUT 12-WEEK DOUBLE-BLIND PERIOD

Reuters · 3d ago

Please log in to view news